Keine Internetverbindung – die gespeicherte Version der Seite wird angezeigt.
← zu den Großinvestoren

Vivo Capital, LLC

institutioneller Anleger · Portfolio $1.10 Mrd. · 47 Positionen · Bericht zum 30.06.2026

Aktienpositionen Bericht für 30.06.2026, eingereicht am 14.08.2026; Veränderung – ggü. 31.03.2026 · 53

UnternehmenAktienWert% des PortfoliosVeränderung im Quartal
Trevi Therapeutics Inc
US:TRVI
5 094 668$95.0 Mio.8.68%—
Praxis Precision Medicines I…
US:PRAX
271 116$90.8 Mio.8.29%−67 779
Erasca Inc
US:ERAS
4 127 412$75.6 Mio.6.90%−8 024 068
ArriVent BioPharma, Inc.
US:AVBP
1 682 097$58.4 Mio.5.34%+796 181
ABIVAX
US:ABVX
414 899$55.3 Mio.5.05%+175 360
Tango Therapeutics, Inc.
US:TNGX
1 379 769$43.1 Mio.3.94%−775 011
Corvus Pharmaceuticals Inc
US:CRVS
2 805 816$41.9 Mio.3.83%—
Bright Minds Biosciences Inc
US:DRUG
557 172$39.1 Mio.3.57%—
Sinovac Biotech Ltd.
CUSIP P8696W104
5 903 000$38.2 Mio.3.49%—
Tenax Therapeutics Inc
US:TENX
2 500 000$36.4 Mio.3.32%+2 291 667
Aclaris Therapeutics Inc
US:ACRS
6 694 637$35.4 Mio.3.23%+27 971
Dyne Therapeutics Inc
US:DYN
1 557 466$34.6 Mio.3.16%—
Dianthus Therapeutics Inc.
US:DNTH
353 998$34.5 Mio.3.15%—
Alto Neuroscience, Inc.
US:ANRO
1 208 858$31.9 Mio.2.91%+173 307
DBV Technologies
US:DBVT
1 844 758$30.3 Mio.2.76%−822 811
SAB Biotherapeutics Inc
US:SABS
7 299 909$28.5 Mio.2.60%−4 120 091
MoonLake Immunotherapeutics
US:MLTX
1 400 000$27.3 Mio.2.49%+400 000
LB PHARMACEUTICALS INC
US:LBRX
800 000$26.0 Mio.2.37%—
Minerva Neurosciences Inc
US:NERV
4 322 747$24.0 Mio.2.19%—
Design Therapeutics Inc
US:DSGN
1 612 903$23.3 Mio.2.13%—
Oric Pharmaceuticals, Inc.
US:ORIC
1 848 786$20.0 Mio.1.83%—
CAMP4 Therapeutics Corporati…
US:CAMP
4 246 568$18.6 Mio.1.69%—
Faeth Therapeutics, Inc.
US:FTH
722 020$18.1 Mio.1.65%—
Achieve Life Sciences Inc
US:ACHV
2 751 032$18.0 Mio.1.64%neu
Compass Therapeutics, Inc.
US:CMPX
7 757 060$17.0 Mio.1.55%−1 788 406
AN2 Therapeutics Inc
US:ANTX
3 153 640$15.3 Mio.1.39%—
Editas Medicine Inc
US:EDIT
3 555 250$11.5 Mio.1.05%neu
Geron Corporation
US:GERN
8 671 797$11.1 Mio.1.01%—
Odyssey Therapeutics, Inc.
US:ODTX
575 000$10.8 Mio.0.98%neu
Eupraxia Pharmaceuticals Inc…
US:EPRX
1 350 000$8.92 Mio.0.81%—

In Unternehmen Unserer Datenbank 24

UnternehmenAnteilAktienBerichtsdatum
InMed Pharmaceuticals Inc14.53%798 3772026-06-30
Minerva Neurosciences Inc9.05%4 322 7472026-06-30
AN2 Therapeutics Inc8.36%3 153 6402026-06-30
SAB Biotherapeutics Inc8.02%7 299 9092026-06-30
CAMP4 Therapeutics Corporati…6.77%4 246 5682026-06-30
Bright Minds Biosciences Inc5.73%557 1722026-06-30
Tenax Therapeutics Inc5.49%2 500 0002026-06-30
Aclaris Therapeutics Inc4.79%6 694 6372026-06-30
OnKure Therapeutics, Inc.4.77%1 927 7102026-06-30
Instil Bio Inc.4.32%292 7432026-06-30
Sera Prognostics Inc4.29%1 650 4402026-06-30
Satellos Bioscience Inc.3.84%813 6662026-06-30
Bolt Biotherapeutics3.76%72 4142026-06-30
Trevi Therapeutics Inc3.58%5 094 6682026-06-30
PepGen Ltd3.36%2 325 0002026-06-30
Corvus Pharmaceuticals Inc3.34%2 805 8162026-06-30
Alto Neuroscience, Inc.3.08%1 208 8582026-06-30
DBV Technologies2.93%1 844 7582026-06-30
Faeth Therapeutics, Inc.2.79%722 0202026-06-30
Design Therapeutics Inc2.58%1 612 9032026-06-30
Alx Oncology Holdings 2.3%3 184 7132026-06-30
Eupraxia Pharmaceuticals Inc…2.08%1 350 0002026-06-30
Unicycive Therapeutics Inc1.97%550 0002026-06-30
Pasithea Therapeutics Corp1.39%465 4712026-06-30
Anzeige